• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
• 5. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Methoxybenzoic acids and derivatives

Introduction to 2,3-Difluoro-6-methoxybenzoic Acid (CAS No. 773873-26-0)

2,3-Difluoro-6-methoxybenzoic acid is a fluorinated aromatic carboxylic acid that has garnered significant attention in the field of pharmaceutical and chemical research due to its versatile structural properties and potential biological activities. This compound, identified by the Chemical Abstracts Service Number (CAS No.) 773873-26-0, belongs to a class of molecules that exhibit unique electronic and steric characteristics, making it a valuable scaffold for the development of novel therapeutic agents.

The molecular structure of 2,3-Difluoro-6-methoxybenzoic acid consists of a benzoic acid core substituted with two fluorine atoms at the 2 and 3 positions, along with a methoxy group at the 6 position. This specific arrangement of functional groups imparts distinct chemical reactivity and biological interactions, which have been explored in various research studies. The presence of fluorine atoms, in particular, is known to enhance metabolic stability, binding affinity, and overall pharmacological efficacy, making this compound a promising candidate for drug discovery.

In recent years, there has been a growing interest in fluorinated benzoic acids due to their role as key intermediates in the synthesis of active pharmaceutical ingredients (APIs). The unique electronic properties of fluorine atoms can influence the conformation and reactivity of adjacent functional groups, leading to compounds with enhanced bioavailability and target specificity. For instance, studies have demonstrated that fluorinated aromatic compounds can exhibit improved binding to biological targets such as enzymes and receptors, thereby increasing their therapeutic potential.

One of the most compelling aspects of 2,3-Difluoro-6-methoxybenzoic acid is its potential application in the development of anti-inflammatory and analgesic agents. Research has shown that benzoic acid derivatives can modulate inflammatory pathways by inhibiting key enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX). The introduction of fluorine atoms into the benzoic acid scaffold can further enhance these effects by improving enzyme inhibition kinetics. Additionally, the methoxy group at the 6 position can serve as a site for further functionalization, allowing for the synthesis of more complex derivatives with tailored biological activities.

Another area where 2,3-Difluoro-6-methoxybenzoic acid has shown promise is in the field of anticancer research. Fluorinated aromatic compounds have been extensively studied for their ability to interfere with cancer cell proliferation and survival. The electron-withdrawing nature of fluorine atoms can enhance the reactivity of carboxylic acid groups, enabling them to participate in various biochemical reactions. Moreover, studies have indicated that fluorinated benzoic acids can induce apoptosis in cancer cells by disrupting mitochondrial function and activating stress signaling pathways.

The synthesis of 2,3-Difluoro-6-methoxybenzoic acid typically involves multi-step organic reactions starting from commercially available precursors such as mesitylene or fluorene derivatives. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions have been employed to introduce fluorine atoms at specific positions on the aromatic ring. The methoxy group is usually introduced through nucleophilic substitution reactions or direct methylation processes. These synthetic routes highlight the compound's accessibility and feasibility for large-scale production.

In terms of analytical characterization, 2,3-Difluoro-6-methoxybenzoic acid is typically analyzed using high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS). These techniques provide detailed information about the compound's purity, molecular structure, and chemical environment. HPLC is particularly useful for assessing impurities and ensuring compliance with pharmaceutical-grade standards. NMR spectroscopy offers insights into the connectivity and arrangement of atoms within the molecule, while MS helps confirm its molecular weight and fragmentation patterns.

The pharmacokinetic properties of 2,3-Difluoro-6-methoxybenzoic acid are also subjects of ongoing research. Studies have investigated its absorption, distribution, metabolism, excretion (ADME) profiles to better understand how it behaves within biological systems. Fluorinated compounds are known to exhibit favorable pharmacokinetic profiles due to their enhanced lipophilicity and metabolic stability. These properties can contribute to improved bioavailability and prolonged half-life upon administration.

Future directions in the study of 2,3-Difluoro-6-methoxybenzoic acid may include exploring its role in drug delivery systems and nanotechnology applications. The compound's ability to interact with biological targets suggests potential use in targeted drug delivery formulations designed to enhance therapeutic efficacy while minimizing side effects. Additionally, its structural features make it a suitable candidate for incorporation into nanocarriers such as liposomes or polymeric micelles.

In conclusion,2,3-Difluoro-6-methoxybenzoic acid (CAS No. 773873-26-0) represents a fascinating molecule with significant potential in pharmaceutical research. Its unique structural features and biological activities make it a valuable tool for developing novel therapeutic agents across various disease areas. As research continues to uncover new applications for this compound,2,3-Difluoro-6-methoxybenzoic acid is poised to play an increasingly important role in drug discovery and development efforts worldwide.

• 1980050-06-3(6-Ethoxy-2,3,4-trifluorobenzoic acid)
• 947279-31-4(2,3-Difluoro-6-phenylmethoxybenzaldehyde)
• 137654-21-8(2-Fluoro-6-methoxybenzoic acid)
• 1431329-81-5(6-Ethoxy-2,3-difluorobenzoic acid)
• 38512-77-5(Benzoic acid, 2,3,4,5-tetrafluoro-6-methoxy-)
• 1706446-21-0(2,3-Difluoro-5-methoxy-4-methylbenzoic acid)
• 941608-36-2(2-Benzyloxy-6-Fluoro-Benzoic Acid)
• 749230-47-5(2,3-Difluoro-6-hydroxybenzoic acid)
• 1427416-12-3(2-fluoro-6-methoxy-4-methylbenzoic acid)
• 773876-05-4(2,3-Difluoro-6-methoxybenzoic acid methyl ester)